Study identifies key drivers of microbiome-linked cancer immunotherapy side effect
Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of immunotherapy patients to experience serious side effects and showed that diet and microbiome composition influence the side effect's severity.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Modulating GPCR signaling could help delay multiple age-related diseases
United Kingdom
-
Why using AI saves doctors time but won't fix physician burnout
United Kingdom
-
Lab study shows needle-free mRNA vaccine protects against COVID and flu
United Kingdom
-
Obesity impairs key immune cells but bariatric surgery reverses damage
United Kingdom
-
AGA/AASLD joint guideline evaluates newer medications for primary biliary cholangitis
United Kingdom
-
New survey reveals how chronic stress impacts U.S. adults
United Kingdom
-
Napoleon can be partly blamed for Gen Z's weightlifting obsession—here's why
United Kingdom
-
Human neural stem cells found to be susceptible to SARS-CoV-2 variants
United Kingdom